FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006021893> ?p ?o ?g. }

• W2006021893 endingPage "1110" @default.
• W2006021893 startingPage "1099" @default.
• W2006021893 abstract "Tigecycline is the first commercially available member of the glycylcyclines, a new class of antimicrobial agents. The glycylcyclines are derivatives of the tetracycline antibiotics, with structural modifications that allow for potent gram-positive, gram-negative, and anaerobic activity, including certain multidrug-resistant strains. The enhanced activity can be attributed to stronger binding affinity and enhanced protection against several mechanisms of resistance that affect other antibiotic classes such as tetracyclines. Tigecycline exhibits generally bacteriostatic action by reversibly binding to the 30S ribosomal subunit and inhibiting protein translation. In vitro activity has been demonstrated against multidrug-resistant gram-positive pathogens including methicillin-resistant and glycopeptide-intermediate and -resistant Staphylococcus aureus, as well as vancomycin-resistant enterococci. Multidrug-resistant gram-negative pathogens, such as Acinetobacter baumannii and extended-spectrum β-lactamase–producing Klebsiella pneumoniae and Escherichia coli, are typically highly susceptible to tigecycline. The drug also has displayed significant activity against many clinically important anaerobic organisms. This agent demonstrates a predictable pharmacokinetic profile and minimal drug interactions, and is generally well tolerated, with nausea being the most common adverse event. It was approved in June 2005 for the treatment of complicated skin and skin structure infections (SSSIs) and complicated intraabdominal infections. Currently, a limited number of broad-spectrum antimicrobials are available to combat multidrug-resistant organisms. The addition of new agents is essential to limiting the spread of these pathogens and improving outcomes in patients with these types of infections. Tigecycline has demonstrated promising results in initial in vitro and clinical studies for SSSIs and complicated intraabdominal infections; however, further clinical experience will clarify its role as a broad-spectrum agent." @default.
• W2006021893 created "2016-06-24" @default.
• W2006021893 creator A5041850762 @default.
• W2006021893 creator A5084829703 @default.
• W2006021893 date "2006-08-01" @default.
• W2006021893 modified "2023-09-25" @default.
• W2006021893 title "Tigecycline: First of a New Class of Antimicrobial Agents" @default.
• W2006021893 cites W1521047189 @default.
• W2006021893 cites W1970548642 @default.
• W2006021893 cites W1973393074 @default.
• W2006021893 cites W1976898407 @default.
• W2006021893 cites W1983065251 @default.
• W2006021893 cites W1988750503 @default.
• W2006021893 cites W1990434517 @default.
• W2006021893 cites W1993543372 @default.
• W2006021893 cites W1993886815 @default.
• W2006021893 cites W1998455639 @default.
• W2006021893 cites W2001555823 @default.
• W2006021893 cites W2026377811 @default.
• W2006021893 cites W2031303083 @default.
• W2006021893 cites W2034482054 @default.
• W2006021893 cites W2040587302 @default.
• W2006021893 cites W2049692280 @default.
• W2006021893 cites W2054740361 @default.
• W2006021893 cites W2059327436 @default.
• W2006021893 cites W2067724722 @default.
• W2006021893 cites W2069416660 @default.
• W2006021893 cites W2072175080 @default.
• W2006021893 cites W2076728316 @default.
• W2006021893 cites W2080598875 @default.
• W2006021893 cites W2083296033 @default.
• W2006021893 cites W2088785016 @default.
• W2006021893 cites W2098300624 @default.
• W2006021893 cites W2102928406 @default.
• W2006021893 cites W2109434703 @default.
• W2006021893 cites W2110519991 @default.
• W2006021893 cites W2112578254 @default.
• W2006021893 cites W2115202347 @default.
• W2006021893 cites W2117957593 @default.
• W2006021893 cites W2118094416 @default.
• W2006021893 cites W2125283507 @default.
• W2006021893 cites W2128427874 @default.
• W2006021893 cites W2137408524 @default.
• W2006021893 cites W2139818499 @default.
• W2006021893 cites W2140383361 @default.
• W2006021893 cites W2146153077 @default.
• W2006021893 cites W2146332544 @default.
• W2006021893 cites W2146844783 @default.
• W2006021893 cites W2149365938 @default.
• W2006021893 cites W2152567832 @default.
• W2006021893 cites W2153590024 @default.
• W2006021893 cites W2157622488 @default.
• W2006021893 cites W2167119990 @default.
• W2006021893 cites W2168550647 @default.
• W2006021893 cites W2169504919 @default.
• W2006021893 cites W2169655887 @default.
• W2006021893 cites W2170664206 @default.
• W2006021893 cites W2170885587 @default.
• W2006021893 cites W4233550107 @default.
• W2006021893 cites W4235696763 @default.
• W2006021893 doi "https://doi.org/10.1592/phco.26.8.1099" @default.
• W2006021893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16863487" @default.
• W2006021893 hasPublicationYear "2006" @default.
• W2006021893 type Work @default.
• W2006021893 sameAs 2006021893 @default.
• W2006021893 citedByCount "161" @default.
• W2006021893 countsByYear W20060218932012 @default.
• W2006021893 countsByYear W20060218932013 @default.
• W2006021893 countsByYear W20060218932014 @default.
• W2006021893 countsByYear W20060218932015 @default.
• W2006021893 countsByYear W20060218932016 @default.
• W2006021893 countsByYear W20060218932017 @default.
• W2006021893 countsByYear W20060218932018 @default.
• W2006021893 countsByYear W20060218932019 @default.
• W2006021893 countsByYear W20060218932020 @default.
• W2006021893 countsByYear W20060218932021 @default.
• W2006021893 countsByYear W20060218932022 @default.
• W2006021893 countsByYear W20060218932023 @default.
• W2006021893 crossrefType "journal-article" @default.
• W2006021893 hasAuthorship W2006021893A5041850762 @default.
• W2006021893 hasAuthorship W2006021893A5084829703 @default.
• W2006021893 hasConcept C104317684 @default.
• W2006021893 hasConcept C133936738 @default.
• W2006021893 hasConcept C2776315533 @default.
• W2006021893 hasConcept C2777027569 @default.
• W2006021893 hasConcept C2777058267 @default.
• W2006021893 hasConcept C2777637488 @default.
• W2006021893 hasConcept C2778980435 @default.
• W2006021893 hasConcept C2779489039 @default.
• W2006021893 hasConcept C2781414143 @default.
• W2006021893 hasConcept C4937899 @default.
• W2006021893 hasConcept C501593827 @default.
• W2006021893 hasConcept C523546767 @default.
• W2006021893 hasConcept C54355233 @default.
• W2006021893 hasConcept C547475151 @default.
• W2006021893 hasConcept C55493867 @default.
• W2006021893 hasConcept C71924100 @default.
• W2006021893 hasConcept C86803240 @default.

• next